Loading clinical trials...

NOT_YET_RECRUITING

Evaluating Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index

An Open Observational Study to Evaluate Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index

NCT07161557•Amway (China) R&D Center

Summary

The goal of this observational study is to evaluate Metabolic Health by fit analysis between calculated Nutrilite Metabolic Health Index and the result of Metabolomics analysis from blood plasma samples in healthy adult participants aged between 18 and 60 years. The main question it aims to answer: \- Does the Nutrilite Metabolic Health Index fit well with the result of Metabolomics analysis from blood plasma samples? 200 eligible participants will be enrolled in a single center, one site visit will be made to finish a health questionnaire, a lifestyle questionnaire, a routine physical checkup. Blood samples will be collected for routine blood test (blood sugar, total triglycerides, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, uric acid), and for Metabolomics testing. Researchers will calculate the Nutrilite Metabolic Health Index based on participant data, and do the fit analysis against the result from Metabolomics analysis.

Eligibility

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Male and female volunteers, aged 18 to 60, regardless of gender;
•Not participating in other interventional clinical studies;
•Have a good understanding of the nature, purpose, benefits obtained, and possible risks and side effects of the study;
•Willing to comply with all trial requirements and procedures;
•Sign the informed consent form.

Exclusion Criteria

•In the treatment of gastrointestinal symptoms;
•Those who are lactose intolerant, allergic to fish and their products;
•Current suffering from other organic diseases affecting bowel function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, Hirschsprung's disease, scleroderma, anorexia nervosa, etc.;
•Diet control, exercise enhancement, or taking medications that control weight or affect appetite in the past 3 months;
•Volunteers have any of the following medical history or have been clinically diagnosed with the following diseases that may affect the evaluation of the test results: obvious gastrointestinal disorders, liver, kidney, endocrine, blood, respiratory and cardiovascular diseases;
•Current or past abuse of alcohol or other illicit drugs, supplements, or OTC prescriptions 3 / 11 Research content Collection of biological samples or information data Evaluation indicators Drugs may cause intestinal dysfunction or affect the evaluation of trial effects;
•Frequent use of drugs that may affect gastrointestinal function or immune system according to the investigator's judgment.

Locations (1)

Shanghai MCC Hospital

Shanghai, Shanghai Municipality, China

Key Dates

Start Date

October 9, 2025

Primary Completion Date

April 10, 2026

Completion Date

May 10, 2026

Last Updated

September 12, 2025

Enrollment

200

ESTIMATED participants

Conditions

Metabolic AbnormalityMetabolic Disorders

Interventions

No Intervention: Observational Cohort

OTHER

Contacts

Charlie Zhang, MD

CONTACT

+8613901981272 charlie.zhang@raisonbiotech.com

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

NCT03128996

Severe Sickle Cell DiseaseBone Marrow Failure Syndromes+4 more

View study

RECRUITING

A Natural History Study of Metabolic Sizing in Health and Disease

NCT05398783

Metabolic DisordersCancer+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 12, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Evaluating Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index

Inclusion Criteria

Exclusion Criteria

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

A Natural History Study of Metabolic Sizing in Health and Disease

MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders

Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500